Latest Views & News

Here's A Covid-Testing Outfit that Could Still Be Worth a Look

By Malcolm Stacey | Wednesday 27 January 2021


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Hello Share Chasers. The share price of Avacta (AVCT) shares is holding up rather well, considering that vaccines will soon render the virus far less common. Perhaps the world expects testing to be needed until the virus disappears altogether. And we all know that’s unlikely. So, if Avacta shares continue to do well, perhaps we could consider another company which also has some news on the testing front…

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

|